Beta

Spending
Congress
Stocks
Lobbying

Spending
Congress
Stocks
Lobbying

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Congress
Stocks
Lobbying

3-V BIOSCIENCES, INC. — Lobbying — Receipts Report

LD-2 disclosure · Registration - Amendment

3-V BIOSCIENCES, INC.

via FABIANI & COMPANY

1st Quarter (Jan 1 - Mar 31) · 2009Posted Apr 14, 2009Filing document ↗LDA record ↗

Coverage · Registration amendment — updates registrant or client details already on file; not a periodic activity report.

Client

Name: 3-V BIOSCIENCES, INC.
Description: Development of pharmaceuticals to address unmet needs in infectious disease
Location: California · United States of America

Registrant

Firm: FABIANI & COMPANY
Description: Global trade
Location: Washington, District of Columbia, United States of America

Lobbying activities

2 issues

Defense
Pursuing government funding to support therapeutic platform development for infectious diseases
Lobbyistsms WENDY SHELTON dvm · mr JAMES P FABIANI · mr STEPHEN R CONAFAY · MELISSA DUPREE
Health Issues
Pursuing government funding to support therapeutic platform development for infectious diseases
Lobbyistsms WENDY SHELTON dvm · mr JAMES P FABIANI · mr STEPHEN R CONAFAY · MELISSA DUPREE

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.